Tidal Investments’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,943
Closed -$57.4K 1843
2024
Q4
$57.4K Sell
1,943
-49
-2% -$4.11K ﹤0.01% 1799
2024
Q3
$175K Sell
1,992
-97
-5% -$8.13K ﹤0.01% 1757
2024
Q2
$143K Sell
2,089
-814
-28% -$96.8K ﹤0.01% 1725
2024
Q1
$502K Sell
2,903
-182
-6% -$22.6K 0.01% 1198
2023
Q4
$379K Sell
3,085
-121
-4% -$10.5K 0.01% 1065
2023
Q3
$273K Buy
3,206
+1,437
+81% +$183K 0.01% 1098
2023
Q2
$265K Hold
1,769
0.01% 1092
2023
Q1
$237K Buy
1,769
+1,082
+157% +$195K 0.01% 1114
2022
Q4
$283K Sell
687
-131
-16% -$54.3K 0.01% 877
2022
Q3
$315K Sell
818
-1,772
-68% -$580K 0.01% 729
2022
Q2
$369K Buy
+2,590
New +$412K 0.01% 701

Other funds holding BCAB

Tidal Investments's BCAB Position: Q1 2025 in Review

Tidal Investments sold out of BioAtla (BCAB) in Q1 2025, closing a stake of 1,943 shares — an estimated $57.4K sold.

Tidal Investments first reported a position in BCAB in Q2 2022 and held it in 11 quarters. The position peaked at $502K in Q1 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

  • Tidal Investments reported no remaining BioAtla position as of Q1 2025 after selling out during the quarter.
  • Tidal Investments sold 1,943 BioAtla shares in Q1 2025, an estimated $57.4K.
  • Tidal Investments first reported a position in BioAtla in Q2 2022 and held it in 11 quarters.
  • Tidal Investments's BioAtla position peaked at $502K in Q1 2024.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q1 2025.

Based on Tidal Investments's 13F filing for Q1 2025, filed 14 May 2025.